Effect of zinc-carnosine complex on muscular function in frail distrophin-deficient (mdx) mice

Japanese Journal of Physiology

Volumn 52, Issue 5, 2002, Pages 449-456

  Tameyasu, Tsukasa ^a   Ohta, Megumi ^a   Tanaka, Midori ^a   Ogihara, Kyoko ^a   Takahashi, Saeko ^b   Yamanobe, Tomoyo ^c  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Technology Department / Yonezawa Hamari Chemicals Ltd 2 4300 18   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

Author keywords

Carnosine; EDL muscle; Fatigue; Muscular dystrophy; Zinc

Indexed keywords

CALCIUM; DYSTROPHIN; POLAPREZINC;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DUCHENNE MUSCULAR DYSTROPHY; EXTENSOR DIGITORUM LONGUS MUSCLE; FEMALE; FORCE; GASTROCNEMIUS MUSCLE; MALE; MOUSE; MOUSE STRAIN; MUSCLE CONTRACTILITY; MUSCLE FATIGUE; MUSCLE FUNCTION; MUSCLE LEVEL; MUSCLE MASS; MUSCLE STRENGTH; MUSCLE TWITCH; NONHUMAN; SLOW MUSCLE FIBER; WEIGHT BEARING;

ANIMALS; BODY WEIGHT; CARNOSINE; DYSTROPHIN; FOOT; INJECTIONS, INTRAPERITONEAL; METABOLISM, INBORN ERRORS; MICE; MICE, INBRED MDX; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; ORGANOMETALLIC COMPOUNDS; TIME FACTORS; WEIGHT-BEARING;

EID: 0036825395     PISSN: 0021521X     EISSN: None     Source Type: Journal    
DOI: 10.2170/jjphysiol.52.449     Document Type: Article

References (25)

1. Gillis JM: Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse. J Musc Res Cell Motil 20: 605-625, 1999
2. Sabine DLP, Sophie M, and Koenig J: Characteristics of skeletal muscle in mdx mutant mice. Int Rev Cytol 191: 99-148, 1999
3. Moens P, Baatsen PHWW, and Marechal G: Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Musc Res Cell Motil 14: 446-451, 1993
4. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, and Sweeney HL: Dystrophin protests the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90: 3710-3714, 1993
5. Brenman JE, Chao DS, Xia H, Aldape K, and Bredt DS: Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82: 743-752, 1995
6. Chang WJ, Iannaccone ST, Lau KS, Masters BS, McGabe TJ, McMillan K, Radre RC, Spencer MJ, Tidball JG, and Stull JT: Neuronic nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci USA 93: 9142-9147, 1996
7. Bodensteiner JB and Angel AG: Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibres in 114 biopsies. Neurology 28: 439-446, 1978
8. McArdle A, Edwards RHT, and Jackson MJ: Accumulation of calcium by normal and dystrophin-deficient mouse muscle during contractile activity in vitro. Clin Sci 82: 455-459, 1992
9. Gailly P, Boland B, Himpens B, Casteels R, and Gillis JM: Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice. Cell calcium 14: 437-483, 1993
10. Metzinger L, Passaquin AC, Warter JM, and Poindron P: α-Methylprednisone promotes skeletal myogenesis in dystrophin-deficient and control mouse cultures. Neurosci Lett 155: 171-174, 1993
11. Passaquin AC, Methzinger L, Leger JJ, Warter JM, and Poindron P: Prednisone enhances myogenesis and dystrophin-related protein in skeletal muscle cell cultures from mdx mouse. J Neurosci Res 35: 363-372, 1993
12. Anderson JE, McIntosh LM, and Poettcker R: Deflazacort but not prednisone improves both repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse. Muscle Nerve 19: 1576-1585, 1996
13. Distnik MH, Dhawan J, Yu Y, Beal MF, Whirl MM, Franco AA, and Rando TA: Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state. J Neurol Sci 26: 77-84, 1998
14. Jackson MJ and Edwards RHT: Therapeutic trials of antioxidants in muscle diseases. In: Oxidative Stress in Skeletal Muscle, ed. Reznik AZ, Packer L, Sen CK, Holloszy JO, and Jackson MJ, Birkhäuser Verlag, Basel, pp 327-333, 1998
15. Rando TA, Disatnik MH, Yu Y, and Franco AA: Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscul Disord 8: 14-21, 1998
16. Cho CH, Luk CT, and Ogle CW: The membrane-stabilizing action of zinc carnosine (Z-103) in stress-induced gastric ulceration in rats. Life Sci 49: 189-194, 1991
17. Yoshikawa T, Naito Y, Tanigawa T, Yoneta T, and Kondo M: The antioxidant properties of a novel zinc-carnosine chelate compound, N-(3-aminopropinyl)-L-histidinato zinc. Biochim Biophys Acta 1115: 15-22, 1991
18. Tameyasu T, Yamada M, Tanaka M, and Takahashi S: Effect of zinc-carnosine chelate compound on muscle function in mdx mouse. Jpn J Physiol 52: 111-120, 2002
19. Deconinck N, Tinsley J, Backer FD, Fisher R, Kahn D, Phelps S, Davies K, and Gillis JM: Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nat Med 3: 1216-1221, 1997
20. Hayes A, Lynch GS, and Williams DA: The effects of endurance exercise on dystrophic mdx mice. I. Contractile and histochemical properties of intact muscles. Proc R Soc Lond B 253: 19-25, 1993
21. Dupont-Versteegden EE and Mccarter RJ: Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice. Muscle Nerve 15: 1105-1110, 1992
22. Carnwath JW and Shotton DM: Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. J Neuro Sci 80: 39-54, 1987
23. Pastoret C and Sebille A: Mdx mice show progressiveweakness and muscle deterioration with age. J Neurol Sci 129: 97-105, 1995
24. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, Watt DJ, Dickson JG, Tinsley JM, and Davies KE: Utorophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90: 717-727, 1997
25. Seto K, Yoneta T, Suda H, and Tamaki H: Effect of polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc), a novel antiulcer agent containing zinc, on cellular proliferation: role of insulin-like growth factor I. Biochem Pharmacol 58: 245-250, 1999